| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad1f2c153505db8151859ff19525ca74 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2016-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e333b2f3e6e70415064a9aa411d2e8a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99586e0305630095f3aeaa8864d39ff3 |
| publicationDate |
2017-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2016201937-A1 |
| titleOfInvention |
Combination therapy with a6 and chemotherapeutic agents for the treatment of cancer |
| abstract |
Provided herein are therapeutic combinations of A6 peptide (SEQ ID NO: 1) and anti cancer agents and the use of such combinations in the treatment of cancer. |
| priorityDate |
2016-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |